Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.47 |
| ▸ | GAPDH | P04406 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.43 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.42 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160811 | 1.00 | TRPA1 (0.47) | TRPA1DDAH1GAPDHMAPTLMNA | |
| SCHEMBL27642615 | 0.98 | EGFR (0.47) | TRPA1DDAH1GAPDHMAPTLMNA | |
| SCHEMBL6897132 | 0.87 | MEN1 (0.42) | TDP1HDAC3 | |
| SCHEMBL6897130 | 0.87 | MEN1 (0.42) | TDP1HDAC3 | |
| SCHEMBL300790 | 0.86 | LMNA (0.45) | TRPA1DDAH1GAPDHMAPTLMNA | |
| Pyruvate SCHEMBL28628122 | 0.86 | ACHE (0.49) | LMNAEGFRTDP1LTB4RHDAC3 | |
| SCHEMBL12055605 | 0.85 | CSNK1E (0.47) | LMNAEGFRTDP1CSNK1EHDAC3 | |
| SCHEMBL28880268 | 0.83 | HTR2A (0.40) | MAPTALDH1A1POLB | |
| SCHEMBL23357393 | 0.82 | CYP1A2 (0.41) | MAPTLMNAALDH1A1RECQLHDAC3 | |
| SCHEMBL9111068 | 0.81 | EGFR (0.43) | MAPTLMNAEGFRTDP1CSNK1E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113545994-A | Plant source composite bacteriostatic agent and application thereof | 广州艾卓生物科技股份有限公司 | 2021-10-26 | — | — | CN | claimed |
| US-8603962-B2 | Methods for treating fabric in a dryer with a composition comprising silicic acid esters | THE DIAL CORPORATION (US) | 2013-12-10 | — | — | US | claimed |
| EP-2142631-B1 | METHODS FOR TREATING FABRIC IN A DRYER | DIAL CORP (US) | 2012-03-14 | — | — | EP | claimed |
| EP-2142631-A1 | METHODS FOR TREATING FABRIC IN A DRYER | The Dial Company (US) | 2010-01-13 | — | — | EP | claimed |
| WO-2008134212-A1 | METHODS FOR TREATING FABRIC IN A DRYER | THE DIAL COMPANY (US) | 2008-11-06 | — | — | WO | claimed |
| EP-0786247-B1 | SUSTAINED-RELEASE AROMATIC AND METHOD OF DETECTING MICROORGANISM BY USING THE SAME | KANEBO COSMETICS INC (JP) | 2005-08-17 | — | — | EP | claimed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| US-6576247-B1 | Applying perfume derivative, selected from glycoside, phosphoric acid ester and/or amino acid derivative, on skin such that microorganism present on skin releases perfume component from derivative, thereby producing aroma | KANEBO LTD. AND T. HASEGAWA CO. LTD. (JP) | 2003-06-10 | — | — | US | claimed |
| EP-1056739-B1 | NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE | PROCTER & GAMBLE (US) | 2003-05-02 | — | — | EP | claimed |
| US-6500797-B1 | Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones | THE PROCTER & GAMBLE COMPANY | 2002-12-31 | — | — | US | claimed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| EP-4396133-A1 | METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL | Omya International AG (CH) | 2024-07-10 | — | — | EP | disclosed |
| EP-4146743-B1 | COATINGS COMPRISING ANTIMICROBIAL ACTIVE INGREDIENTS FOR FOOD PACKAGING | OMYA INT AG (CH) | 2024-07-03 | — | — | EP | disclosed |
| US-20240016966-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | Arylessence, Inc. | 2024-01-18 | — | — | US | disclosed |
| US-6013618-A | ORTHOESTERS, KETALS, ACETALS, ORTHOCARBONATES WHICH RELEASE TWO OR MORE FRAGRANCE RAW MATERIALS UPON HYDROLYSIS | PROCTER & GAMBLE COMPANY (US) | 2000-01-11 | — | — | US | disclosed |
| US-5919752-A | ORTHOESTERS, KETALS, ACETALS, ORTHOCARBONATES WHICH RELEASE TWO OR MORE FRAGRANCE RAW MATERIALS UPON HYDROLYSIS. | PROCTER & GAMBLE (US) | 1999-07-06 | — | — | US | disclosed |
| WO-1998007809-A2 | HARD SURFACE CLEANERS COMPRISING β-KETOESTER PRO-FRAGRANCES | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
| WO-1998007810-A2 | HAND-WASH LAUNDRY DETERGENT COMPOSITIONS COMPRISING BETA-KETOESTER PRO-FRAGRANCES | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
| US-3953524-A | Catalytic hydrogenation of alpha,beta-unsaturated aldehydes to alpha,beta-unsaturated alcohols | HOFFMANN-LA ROCHE INC. (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | TRPA1 5/4885DDAH1 3090/4885GAPDH 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.